Version 5.4
Bos taurus Protein: TAF13
Summary
InnateDB Protein IDBP-687459.2
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol TAF13
Protein Name Transcription initiation factor TFIID subunit 13
Synonyms
Species Bos taurus
Ensembl Protein ENSBTAP00000042334
InnateDB Gene IDBG-635615 (TAF13)
Protein Structure
UniProt Annotation
Function TFIID beta-specific TAFII. {ECO:0000250}.
Subcellular Localization Nucleus {ECO:0000250}.
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
They are also associated with 18 interaction(s) predicted by orthology.
Predicted by orthology
Total 18 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0003677 DNA binding
GO:0005515 protein binding
GO:0008022 protein C-terminus binding
GO:0046982 protein heterodimerization activity
Biological Process
GO:0006351 transcription, DNA-templated
GO:0006355 regulation of transcription, DNA-templated
GO:0006366 transcription from RNA polymerase II promoter
Cellular Component
GO:0005634 nucleus
GO:0005669 transcription factor TFIID complex
GO:0005730 nucleolus
Protein Structure and Domains
PDB ID
InterPro IPR003195 Transcription initiation factor IID, 18kDa subunit
IPR009072 Histone-fold
PFAM PF02269
PRINTS
PIRSF
SMART
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt Q148M7
PhosphoSite PhosphoSite-
TrEMBL
UniProt Splice Variant
Entrez Gene 790401
UniGene Bt.26935
RefSeq NP_001069065
HUGO
OMIM
CCDS
HPRD
IMGT
EMBL BC118136
GenPept AAI18137

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca